Back to search

Article

Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination

2025-11-02

Abstract excerpt

Ongoing escape from pre-existing antibodies by severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) necessitates yearly coronavirus disease 2019 (COVID-19) vaccine updates for at-risk populations. Monovalent variant-specific booster vaccines, such as those for XBB.1.5, JN.1, and LP.8.1, aim to re-direct immune responses towards antigenically distinct variants; However, immune imprinting by multipl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7a2d89e-883a-5bd8-91a0-5625814c886e
DOI
10.1101/2025.10.30.25339006
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccinationDOI 10.1101/2025.10.30.25339006
Select a neighboring publication to make it the new centre.